Centiva Capital’s OptimizeRx OPRX Stock Holding History

Centiva Capital’s Portfolio OPRX Stock Details OPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$97.3K	Sell	17,003 -9,570	-36%	-$55K	﹤0.01%	1526
2026 Q1	$167K	Buy	+26,573	New	+$247K	﹤0.01%	1318
2025 Q3	–	Sell	-12,274	Closed	-$166K	–	1633
2025 Q2	$166K	Buy	+12,274	New	+$134K	﹤0.01%	1366
2019 Q1	–	Sell	-18,627	Closed	-$204K	–	354
2018 Q4	$204K	Buy	+18,627	New	+$276K	0.02%	213

Other funds holding OPRX

WCA

Whetstone Capital Advisors Shawnee Mission, Kansas $380M AUM 20.01% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

KCM

Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return

William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $977M AUM 110.37% 1-Year Est. Return

Centiva Capital's OPRX Position: Q2 2026 in Review

Centiva Capital reduced its OptimizeRx (OPRX) stake by 36% in Q2 2026, selling an estimated $55K and leaving 17,003 shares worth $97.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1526.

Centiva Capital first reported a position in OPRX in Q4 2018 and has held it in 4 quarters since. The position peaked at $204K in Q4 2018. 113 funds tracked by Wall St. Rank hold OPRX as of Q2 2026.

Centiva Capital held 17,003 shares of OptimizeRx worth $97.3K as of Q2 2026.
Centiva Capital sold 9,570 OptimizeRx shares in Q2 2026, an estimated $55K.
OptimizeRx made up ﹤0.01% of Centiva Capital's portfolio in Q2 2026, its #1526 holding.
Centiva Capital first reported a position in OptimizeRx in Q4 2018 and has held it in 4 quarters since.
Centiva Capital's OptimizeRx position peaked at $204K in Q4 2018.
113 funds tracked by Wall St. Rank held OptimizeRx as of Q2 2026.

Based on Centiva Capital's 13F filing for Q2 2026, filed 13 Aug 2026.